Identification | Back Directory | [Name]
2,4-dichloro-3-fluoropyridine | [CAS]
628691-85-0 | [Synonyms]
2,4-dichloro-3-fluoropyridine 4,6-dichloro-3-fluoro-pyridine Pyridine, 2,4-dichloro-3-fluoro- 2-chloro-3-fluoro-4-chloropyridine | [Molecular Formula]
C5H2Cl2FN | [MDL Number]
MFCD12196994 | [MOL File]
628691-85-0.mol | [Molecular Weight]
165.98 |
Chemical Properties | Back Directory | [Boiling point ]
187.7±35.0 °C(Predicted) | [density ]
1.498±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [pka]
-1.13±0.10(Predicted) |
Hazard Information | Back Directory | [Uses]
2,4-Dichloro-3-fluoropyridine is used in tthe preparation of (aza)indazolyl-aryl sulfonamide and related compounds for inhibiting GCN2 activity | [Synthesis]
1. a mixture of lithium diisopropylamide (2M in heptane/THF/ethylbenzene with 0.5% [w/w] LiBr stabilizer; 3.8 mL, 7.6 mmol) and THF (3 mL) was cooled to -78 °C under nitrogen protection.
2. a solution of 2-chloro-3-fluoropyridine (1.0 g, 7.6 mmol) in THF (2 mL) was added slowly dropwise for a controlled time of 1 minute.
3. After the reaction mixture was stirred at -78°C for 2 hours, a THF (3 mL) solution of hexachloroethane (2.0 g, 8.4 mmol) was added dropwise.
4. Stirring was continued at -78°C for 2 hr followed by quenching the reaction with saturated aqueous NH4Cl solution (20 mL).
5. The reaction mixture was extracted with EtOAc (100 mL) and the organic phase was dried with anhydrous MgSO4 and concentrated under reduced pressure.
6. The crude product was purified by silica gel column chromatography (eluent: 15% Et2O/isohexane) to afford 2,4-dichloro-3-fluoropyridine (795 mg, 63% yield).
7. converting 2,4-dichloro-3-fluoropyridine (495 mg, 3.0 mmol) to 7-chloro-8-fluoroimidazo[1,2-a]pyridine (225 mg, 44% yield) according to the method of Example 1.
8. brominating 7-chloro-8-fluoroimidazo[1,2-a]pyridine (115 mg, 0.67 mmol) according to the method of Example 1 to obtain 3-bromo-7-chloro-8-fluoroimidazo[1,2-a]pyridine (162 mg, 96% yield).
9. Reacting 3-bromo-7-chloro-8-fluoroimidazo[1,2-a]pyridine (45 mg, 0.18 mmol) with 4-fluoro-3-(pyridin-3-yl)phenylboronic acid (49 mg, 0.19 mmol) according to the method of Example 1 , the title compound was obtained as a white amorphous solid (49 mg, 80% yield). | [References]
[1] Patent: US2017/29404, 2017, A1. Location in patent: Paragraph 0102-0105 [2] Patent: WO2003/99816, 2003, A1. Location in patent: Page 51 |
|
|